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ABSTRACT  28 
Aims: To characterize postprandial glucose flux after exercise in the fed versus 29 
overnight fasted-state and to investigate potential underlying mechanisms. 30 
Methods: In a randomized order, twelve men underwent breakfast-rest (BR; 3 h 31 
semi-recumbent), breakfast-exercise (BE; 2 h semi-recumbent before 60-min of 32 
cycling (50% peak power output) and overnight fasted-exercise (FE; as per BE 33 
omitting breakfast) trials. An oral glucose tolerance test (OGTT) was completed 34 
post-exercise (post-rest on BR). Dual stable isotope tracers ([U-13C] glucose 35 
ingestion and [6,6-2H2] glucose infusion) and muscle biopsies were combined to 36 
assess postprandial plasma glucose kinetics and intramuscular signaling, 37 
respectively. Plasma intestinal fatty acid binding (I-FABP) concentrations were 38 
determined as a marker of intestinal damage. Results: Breakfast before exercise 39 
increased post-exercise plasma glucose disposal rates during the OGTT, from 40 
44 g·120 min-1 in FE [35 to 53 g·120 min-1] (mean [normalized 95% CI]) to 73 41 
g·120 min-1 in BE [55 to 90 g·120 min-1; p = 0.01]. This higher plasma glucose 42 
disposal rate was, however, offset by increased plasma glucose appearance 43 
rates (principally OGTT-derived), resulting in a glycemic response that did not 44 
differ between BE and FE (p = 0.11). Plasma I-FABP concentrations during 45 
exercise were 264 pg·mL-1 [196 to 332 pg·mL-1] lower in BE versus FE (p = 0.01).  46 
Conclusion: Breakfast before exercise increases post-exercise postprandial 47 
plasma glucose disposal, which is offset (primarily) by increased appearance 48 
rates of orally-ingested glucose. Therefore, metabolic responses to fed-state 49 
exercise cannot be readily inferred from studies conducted in a fasted state. 50 
Key words: Breakfast; Exercise; Insulin sensitivity; Glycemia; Metabolism  51 
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INTRODUCTION 52 
Postprandial glycemia is a strong predictor of future mortality and morbidity. Even 53 
in people without diabetes, those with greater blood glucose excursions after 54 
feeding are at an increased risk of cardiovascular disease (47, 48). This glycemic 55 
response to food ingestion is dictated by blood glucose kinetics (i.e. the balance 56 
between the rates of glucose appearance into blood and glucose disposal from 57 
blood into peripheral tissues). Exercise potently increases glucose disposal from 58 
the blood into skeletal muscle (52), and regular exercise is therefore 59 
recommended as a lifestyle strategy to improve glycemic control.  60 
 61 
Habitual responses to exercise and nutrition are however, the culmination of not 62 
only chronic adaptations, but also the acute effects of each exposure to these 63 
daily behaviors (5, 6, 22). For example, each bout of exercise potently stimulates 64 
post-exercise insulin sensitivity and muscle glucose uptake (52). However, 65 
despite increases in blood glucose disposal rates, endurance-type exercise does 66 
not always reduce postprandial glucose excursions in the post-exercise period 67 
(20, 54). The finding that postprandial blood glucose concentrations are not 68 
lowered post-exercise is because when exercise is performed (at least in the 69 
fasted state), the increase in postprandial blood glucose disposal after exercise 70 
can be offset - and even superseded - by increases in both endogenous and 71 
meal-derived blood glucose appearance rates (34, 54). 72 
 73 
Whilst fasting prior to laboratory trials is common in order to control for baseline 74 
metabolic status, these conditions may preclude the application of findings to 75 
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situations most representative of daily living. For example, most people living in 76 
developed countries spend the majority of a typical day in the postprandial state 77 
(13, 55). Therefore, most eating occasions and exercise sessions will take place 78 
in the context of this postprandial situation (23). It has previously been shown by 79 
others that plasma glucose fluxes during exercise (16), and by us that plasma 80 
glucose concentrations after exercise (24), are elevated by pre-exercise feeding. 81 
However, the effect of prior feeding on post-exercise plasma glucose flux has 82 
never been assessed. Therefore, there is a distinct lack of understanding 83 
regarding postprandial glucose kinetics under scenarios that are most 84 
representative of daily living, and it may not be valid to generalize existing 85 
observations of exercise in the fasted state. Moreover, an understanding of the 86 
underlying mechanisms responsible for any differences in postprandial glucose 87 
flux post-exercise, with prior feeding versus fasting, is still required. 88 
 89 
This study therefore aimed to characterize postprandial plasma glucose kinetics 90 
after: 1) breakfast and rest; 2) breakfast and exercise and 3) overnight fasted-91 
state exercise, while also exploring potential mechanisms (intramuscular 92 
signaling and markers of intestinal damage) to explain any differences in glucose 93 
flux between these conditions.   94 
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MATERIALS AND METHODS 95 
Ethical Approval 96 
All trials were undertaken at the University of Bath (Bath, UK) in accordance with 97 
the Declaration of Helsinki. The study was approved by the National Health 98 
Service South-West Research Ethics Committee (reference: 15/SW/0006) and 99 
registered at clinicaltrials.gov as NCT02258399. Written, informed consent was 100 
obtained from all participants prior to their participation. 101 
 102 
Study Design 103 
This study was a randomized cross-over design (randomization performed by 104 
JTG with Research Randomizer version 3.0, http://www.randomizer.org/). 105 
Preliminary testing was followed by three trials (separated by > 7 d), namely, 106 
breakfast-rest (BR), breakfast-exercise (BE) and overnight fasted-exercise (FE). 107 
A schematic for the study protocol is shown in Figure 1. For all trials participants 108 
arrived at the laboratory after a 12 to 14-h overnight fast. In BR, a porridge 109 
breakfast was consumed, followed by 3 h of rest, and then a 2-h oral glucose 110 
tolerance test (OGTT). In BE, the same breakfast was consumed, before 2 h rest 111 
and 60 min of cycling, prior to the OGTT. In FE, breakfast was omitted but the 112 
trial otherwise replicated BE. By necessity of design (food intake/exercise) the 113 
intervention was open label. Within-lab testing conditions were not different 114 
across the trials ([mean ± SD] ambient temperature [23.7 ± 0.5 °C on BR, 23.7 ± 115 
0.6 °C on BE, 23.6 ± 0.7 °C on FE) and barometric pressure [734 ± 5 mmHg on 116 
BR, 736 ± 6 mmHg on BE, 736 ± 5 mmHg on FE]; all p > 0.05).  117 
 118 
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 119 
Participants 120 
Twelve healthy and physically active men (self-reported as regular exercisers 121 
engaging in at least 30 min of exercise a minimum of 3 times per week) were 122 
recruited from Bath and North East Somerset, between May and November 2015. 123 
Participant characteristics are shown in Table 1. Exclusion criteria included any 124 
history of metabolic disease, or condition that may have posed undue personal 125 
risk to the participant or introduced bias to the study.  126 
 127 
Preliminary Testing 128 
Participants were asked to refrain from strenuous physical activity for 24 h prior 129 
to preliminary testing, but were asked to otherwise maintain their normal physical 130 
activity behaviors. They abstained from alcoholic and caffeinated drinks for 24 h 131 
Figure 1. Protocol schematic. An oral glucose tolerance test was conducted after 
breakfast followed by rest (BR), breakfast followed by exercise (BE), or extended 
overnight fasting followed by exercise (FE). Dual stable isotope tracers ([U-13C] glucose 
ingestion and [6,6-2H2] glucose infusion) and muscle biopsies were combined to assess 
postprandial plasma glucose kinetics and intramuscular signaling, respectively. 
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prior to this visit. Food intake ceased at 8 pm on the evening before testing and 132 
participants fasted overnight (minimum 12 h), consuming only water (ad libitum) 133 
during this period. In addition, they were asked to consume 568 mL of water at 134 
least 1 h prior to testing, and to void immediately prior to arriving at the laboratory. 135 
Upon arrival, the participant’s stature was measured (Frankfurt plane) to the 136 
nearest 0.1 cm using a stadiometer (Seca Ltd, Birmingham, UK). Body mass was 137 
recorded to the nearest 0.1 kg (only light clothing permitted) using electronic 138 
weighing scales (BC543 Monitor, Tanita, Tokyo, Japan). A whole-body dual 139 
energy x-ray absorptiometry scan was completed to quantify fat and fat-free mass 140 
(DEXA; Discovery, Hologic, Bedford, UK).  141 
 142 
Participants then performed an incremental cycling exercise test at a self-143 
selected cadence on an electronically-braked ergometer (Excalibur Sport, Lode 144 
Lode Groningen, Netherlands). They were permitted to adjust the saddle and 145 
handlebar heights to their preferred position, which were replicated for cycling 146 
during the exercise trials. The initial exercise intensity was 50 W and this was 147 
increased by 50 W every four min, for four stages.  Thereafter, the intensity was 148 
increased by 20 W every min until volitional exhaustion. Heart rate (Polar Electro 149 
Oy, Kempele, Finland) and continuous breath-by-breath measurements were 150 
recorded throughout (TrueOne2400, ParvoMedics, Sandy, USA). Volume and 151 
gas analyzers were calibrated with a 3 L calibration syringe (Hans Rudolph, 152 
Kansas City, USA) and a calibration gas (balance nitrogen mix; 16.04% O2, 153 
5.06% CO2; BOC Industrial Gases, Linde AG, Munich, Germany), respectively. 154 
Peak power output (PPO) was calculated as the work rate of the last completed 155 
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stage, plus the fraction of time spent in the final non-completed stage, multiplied 156 
by the work rate increment. Peak oxygen uptake (VȮ2 peak) was calculated as 157 
the highest average VȮ2 over a rolling 30-s period.  158 
 159 
Main Trials  160 
Participants refrained from strenuous physical activity, alcohol and caffeine for 161 
24 h before all trials. They recorded the composition of their evening meal on the 162 
day before the first main trial and replicated this meal for subsequent trials, in 163 
accordance with procedures for standardizing postprandial glucose tolerance 164 
testing (10). This pre-trial standardisation protocol has been previously shown to 165 
be effective at producing overnight-fasted muscle glycogen concentrations, liver 166 
glycogen concentrations and intramyocellular lipid that are standardised across 167 
multiple trial days, in a similar population (21). To help ensure physical activity 168 
standardization, participants completed a physical activity diary and wore a 169 
physical activity monitor (ActiheartTM; Cambridge Neurotechnology, Papworth, 170 
UK) for 24 h before all trials (pre-trial 24-h physical activity energy expenditure 171 
[(mean ± standard deviation) 988 ± 500 kcal on BR, 1022 ± 521 kcal on BE, 992 172 
± 313 kcal on FE; all p > 0.05; n = 9]. 173 
 174 
Participants arrived at the laboratory at 0800 ± 1 h following a 12 to 14-h overnight 175 
fast and this arrival time was replicated for the subsequent trials. They were 176 
asked to void and all further urine samples were collected for the remainder of 177 
the trial to allow for urinary nitrogen excretion to be estimated from urine urea 178 
concentrations. Participants then placed their dominant hand into a heated-air 179 
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box (Mass Spectrometry Facility; The University of Vermont & University of 180 
Vermont Medical Center, Burlington, USA) set to 55 °C. After 20 min of rest, an 181 
intravenous catheter (BD Venflon Pro, BD, Helsingborg, Sweden) was fitted into 182 
a heated dorsal hand vein (retrograde) and a 10-mL baseline blood sample was 183 
drawn, before a 5-min expired gas sample was collected. On the first main trial 184 
for each participant (see Figure 1), a baseline muscle sample was taken from 185 
the vastus lateralis to allow for an assessment of the pathways involved in 186 
exercise and insulin signaling in muscle [5' AMP-activated protein kinase 187 
(AMPK), acetyl-CoA carboxylase (ACC), protein kinase B (herein refered to as 188 
Akt2), and Akt substrate of 160 kDa (AS160).   189 
 190 
In BE and BR, a porridge breakfast was then consumed within 10 min (3 h pre-191 
OGTT) and in FE participants were allowed water only. The breakfast was 72 g 192 
of instant refined oats (Oatso Simple Golden Syrup, Quaker Oats) and 360 mL of 193 
semi-skimmed milk (Tesco), providing 431 kcal of energy ([1803 kJ]; 65 g CHO, 194 
11 g FAT, 19 g PRO). The breakfast was high-carbohydrate (57% of energy 195 
intake) and high glycemic-index [oatmeal, made from mix (Quaker Oats) has a 196 
glycemic index of 69 (17)], as is commonly consumed in developed countries. 197 
Due to the co-ingestion of milk, this breakfast would produce a high insulinemic 198 
response (38, 46).  Breakfast consumption (or omission on FE) was followed by 199 
2 h of rest, where participants remained in a semi-recumbent position, completing 200 
resting activities (e.g. watching television), with expired gas samples collected 201 
every 60 min. After 1 h 40 min of rest, (1 h 20 min pre-OGTT) a catheter was 202 
inserted into an antecubital vein (the contralateral arm to the one used for blood 203 
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sampling). A primed infusion of [6,6-2H2]glucose was initiated and continued for 204 
the remaining within-lab component of the trial (Cambridge Isotope Laboratories, 205 
MA, USA; prime: 13.5 µmol.kg−1; infusion: 0.35 µmol.kg−1.min−1). After 20 min (60 206 
min pre-OGTT), and on BE and FE only, participants began 60 min of cycling at 207 
50% PPO on an ergometer (Lode Corival, Lode B.V, Groningen, Netherlands). 208 
The cadence was self-selected (replicated for both exercise trials) and the power 209 
output was monitored via a computerized system. In BR, participants remained 210 
rested in the semi-recumbent position during this period. Expired gas samples 211 
were collected every 15 min and blood samples were collected at 40 and 50 min 212 
of exercise (20 and 10 min pre-OGTT). Immediately post-exercise (or post-rest 213 
in BR) a muscle sample was taken from the vastus lateralis. Then a 2-h OGTT 214 
was completed, with arterialized blood sampled at 10-min intervals and expired 215 
gas sampled every 60 min. The OGTT was 73 g of glucose (81 g of dextrose 216 
monohydrate when corrected for water content; Myprotein, Northwich, UK) and 2 217 
g of [U-13C]glucose (99%; Cambridge Isotope Laboratories, MA, USA), to allow 218 
the rate of appearance of the orally ingested glucose (RaOGTT) to be assessed. A 219 
final muscle sample was taken post-OGTT (OGTT 120 min).  220 
 221 
Tracer approach, blood sampling and analysis 222 
A dual-tracer approach was employed, where the tracer infusion rate was 223 
doubled during exercise (on BE and FE) to account for an expected increase in 224 
endogenous glucose production (1) and reduced to 80% of baseline at OGTT 20 225 
min (all trials) to account for an expected suppression of endogenous glucose 226 
production after oral glucose ingestion (9). This approach reduces changes in the 227 
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tracer-to-tracee ratio, thereby permitting more accurate estimations of glucose 228 
kinetics(4). Arterialized blood was sampled from a heated dorsal hand vein at 229 
baseline, at 60-min intervals during the initial 2-h rest period, at 40 and 50 min of 230 
the exercise period (or post-rest in BR) and at 10-min intervals during the OGTT. 231 
Whole blood was dispensed into ethylenediaminetetraacetic acid-coated tubes 232 
(BD, Oxford, UK) which were first centrifuged (4 °C and 3500 g) for 10-min 233 
(Heraeus Biofuge Primo R, Kendro Laboratory Products Plc., UK) to obtain 234 
plasma. The plasma was then dispensed into 0.5 mL aliquots and immediately 235 
frozen at -20 °C, before longer-term storage at -80 °C. 236 
 237 
Plasma glucose (intra-assay coefficient of variation [CV], 3.2%; inter-assay CV 238 
3.8%), lactate (intra-assay CV, 1.0%; inter-assay CV 4.8%), and triglyceride 239 
(intra-assay CV, 1.4%; inter-assay CV 4.0%) concentrations were measured 240 
using an automated analyzer (Daytona; Randox Lab, Crumlin, UK) as per the 241 
manufacturer’s instructions. Plasma insulin concentrations were measured using 242 
a commercially available ELISA kit (Mercodia AB, Uppsala, Sweden; intra-assay 243 
CV, 5.7%; inter-assay CV 9.9%). Plasma intestinal fatty acid binding protein (I-244 
FABP) concentrations were measured as a marker of intestinal cell damage using 245 
a commercially available ELISA kit (Hycult Biotech; intra-assay CV, 6.0%). 246 
Plasma NEFA concentrations were determined using an enzymatic colorimetric 247 
assay (WAKO Diagnostics; intra-assay CV, 8.9%; inter-assay CV 10.4%). For all 248 
of these analyses, all plasma samples were analyzed in batch after all sample 249 
collection was completed, and for a given participant all samples (from the three 250 
trials) were run on the same plate. 251 
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 252 
Plasma [U-13C]glucose and [2H2]glucose enrichments were determined by gas 253 
chromatography-mass spectrometry (GC-MS: GC, Agilent 6890N; MS, Agilent 254 
5973N; Agilent Technologies, Stockport, UK). Plasma glucose was extracted 255 
using methanol-chloroform and hydrochloric acid, dried under nitrogen gas, and 256 
then derivatised using the heptofluorobuyric acid method as previously 257 
described(30). The glucose derivative was acquired by selected ion monitoring 258 
at mass-to-charge ratios (m/z) 519, 521 and 525 for [12C], [6,6-2H2]- and [U-13C]-259 
glucose, respectively. Glucose enrichments of [13C] and [2H2] in plasma were 260 
determined using standard curves for [13C] and [2H2] glucose, and enrichments 261 
were expressed relative to those at 519 (M+0). The baseline sample was used 262 
for every trial to account for background isotopic plasma enrichments. To reduce 263 
any impact of analytical variability on calculations of glucose kinetics, glucose 264 
and enrichment data were curve fitted as previously described (63).  265 
 266 
Muscle sampling and analysis  267 
Muscle samples were collected from the vastus lateralis under local anesthesia 268 
(~5 mL of 1% lidocaine, Hameln Pharmaceuticals Ltd., Brockworth, UK). Samples 269 
were taken from a 3-5-mm incision at the anterior aspect of the thigh with a 5-mm 270 
Bergstrom biopsy needle technique adapted for suction(57). Samples were 271 
immediately extracted from the needle and frozen in liquid nitrogen, before 272 
longer-term storage at -80 °C. The order of dominant or non-dominant leg was 273 
counterbalanced across trials for the OGTT 0 min and the 120 min samples. 274 
Samples were taken from separate skin incision sites, with these > 2 cm proximal 275 
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to any previous incision on the same leg (59). For the OGTT 0 min sample (post 276 
exercise [or post-rest in BR]) the incision was made prior to cycling (BE and FE) 277 
and closed with Steristrips, to allow for an immediate sample to be taken post-278 
exercise. 279 
 280 
Frozen wet tissue (20-30 mg) was freeze-dried, powdered, and dissected free of 281 
visible blood and connective tissue and added to ice cold lysis buffer [50 mM Tris 282 
(pH 7.4), 150 mM NaCl, 0.5% Sodium deoxycholate; 0.1% SDS and 0.1% NP-283 
40] with a protease (Thermo Scientific) and phosphatase inhibitor cocktail 284 
(Millipore). Samples were homogenized with a dounce homogenizer (~ 40 285 
passes), incubated for 60 min at 4 °C with rotation, and centrifuged for 10 min (4 286 
°C and 20,000 g). The protein content of the resultant supernatant was measured 287 
via a bicinchoninic acid (BCA) protein assay kit (Thermo Scientific). For Western 288 
blots, an equal amount of protein (40 µg) was loaded per lane for each sample 289 
and separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis 290 
(SDS-PAGE) on Tris-glycine SDS–polyacrylamide gels (7% for p-AMPKThr172, 291 
total AMPK, p-ACCSer79 and total ACC, 10% for p-AktSer473 and total Akt2 and 8% 292 
for p-AktThr308, p-AS160Thr642 and total AS160). Gels were electro-blotted using a 293 
semi-dry transfer onto a nitrocellulose membrane. Membranes were washed in 294 
Tris-buffered saline (0.09% NaCl, 100 mM Tris–HCl pH 7.4) with 0.1% Tween 20 295 
(TBS-T) and incubated for 30-min in a blocking solution (5% non-fat dry milk in 296 
TBS-T; Marvel, Premier International Foods Ltd, UK). The membranes were 297 
incubated overnight at 4 °C with primary antibodies against p-AMPKThr172, p-298 
ACCSer79, p-AktSer473, p-AktThr308 and p-AS160Thr642 (Cell Signaling Technologies, 299 
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USA). In the morning, membranes were washed in TBS-T and incubated with a 300 
1:4000 dilution of anti-species IgG horseradish peroxidase-conjugated 301 
secondary antibodies made up in the aforementioned blocking solution. After 302 
further washes, membranes were incubated in an enhanced chemiluminescence 303 
(ECL) reagent and visualized using a chemiluminescent imager (EpiChemi II 304 
Darkroom, UVP, Upland, USA). Nitrocellulose membranes were then incubated 305 
for 30-min at 50 °C in a stripping solution [62.5 mM Tris pH 6.7, 2%SDS, 100 mM 306 
2-mercaptoethanol], before re-blotting for total AMPK, total ACC, total Akt2 (Cell 307 
Signaling Technologies, USA) and total AS160 (Merck-Milliopore, UK). For these 308 
analyses, all samples from each participant (all three trials) were run on the same 309 
gel. Band densities were quantified using VisionWorksLS Image Acquisition and 310 
Analysis Software for Windows (UVP, Upland, USA). For all of the signalling 311 
molecules reported in this experiment a ratio of phosphorylated to total protein 312 
was calculated and the results were expressed relative to the baseline sample. 313 
 314 
Substrate utilization 315 
Expired gas samples were collected at baseline, during the initial 2-h rest period 316 
and the OGTT at 60-min intervals (for 5 min), and at 15-min intervals (for 1 min) 317 
during the exercise period (or rest in BR). For all samples, participants were 318 
provided with the mouthpiece 1 min before gas collections for a stabilization 319 
period. Samples were collected in 200 L Douglas bags (Hans Rudolph, Kansas 320 
City, USA) through falconia tubing (Baxter, Woodhouse and Taylor Ltd, 321 
Macclesfield, UK). Concurrent measures of inspired air were made to correct for 322 
changes in ambient O2 and CO2 concentrations(7). Expired O2 and CO2 323 
Page 16 
concentrations were measured in a known volume of each sample, using 324 
paramagnetic and infrared transducers respectively (Mini HF 5200, Servomex 325 
Group Ltd., Crowborough, East Sussex, UK). The sensor was calibrated using 326 
concentrations of low (99.998% Nitrogen, 0% O2 and CO2) and high (balance 327 
nitrogen mix, 16.04% O2, 5.06% CO2) calibration gases (both BOC Industrial 328 
Gases, Linde AG, Munich, Germany).  Urinary nitrogen excretion was estimated 329 
from urine urea concentrations, which were measured on an automated analyzer 330 
(Daytona; Randox Lab, Crumlin, UK), to allow for protein oxidation to be 331 
accounted for in calculations of substrate utilization rates.  332 
 333 
Calculations and statistical analysis 334 
A sample size estimation was completed a priori with the total rate of plasma 335 
glucose appearance as the primary outcome measure. Rose et al. (54) reported 336 
a difference in the total plasma glucose appearance of (mean ± SD) 1600 ± 1300 337 
µmol·kg-1 during an OGTT after rest versus after fasted exercise. Using this effect 338 
size, and an alpha level of 0.05, we calculated that 12 participants were required 339 
for an 80% probability of statistically detecting an effect in the RaTOTAL using a 340 
crossover design with three trials and a two-tailed, one-way ANOVA.   341 
 342 
The total and incremental area underneath the concentration-time curve (AUC or 343 
iAUC, respectively) for each plasma metabolites or hormones was calculated 344 
using the trapezoid rule. The AUC or iAUC for each plasma metabolite or 345 
hormone was then divided by either the duration of the total within-lab period 346 
(300-min) or the OGTT observation period (120-min), as appropriate, to provide 347 
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a time-averaged value (mmol·L-1), which are used as summary measures. 348 
Plasma glucose and insulin concentrations during the OGTT were used to 349 
estimate insulin sensitivity (ISI) according to the equation of Matsuda (41): [FPG 350 
and FPI are fasting plasma glucose and insulin concentrations, and MPG and 351 
MPI are mean plasma glucose and insulin concentrations in the OGTT (41)]: 352 
 353 
ISIMATSUDA(au) =
10,000
√FPG(mgdL-1)•FPI(mIUmL-1)•MPG(mgdL-1)• MPI(mIUmL-1)
 354 
 355 
Plasma glucose kinetics were determined using Radziuk’s two-compartment non-356 
steady state model (50, 51) and SAMM II software (SAAM II v2.3, The Epilson 357 
Group, Charlottesville, VA, USA). This model reduces errors in estimations of 358 
glucose kinetics that are apparent when using Steele’s (56) one compartment 359 
model (53). The total rate of plasma glucose appearance (RaTOTAL) and glucose 360 
disappearance (Rd) were calculated as follows:   361 
 362 
Equation 1: 363 
RaTOTAL(t) =
F
E1(t)
-
V1∙G(t)
E1(t)
∙Ė1(t)+k12 (
q
2
iv(t)
E1(t)
-Q2(t)) 364 
Equation 2: 365 
Rd (t) =RaTOTAL-V1∙Ġ(t) -k21∙V1∙G(t) +k12∙Q2(t) 366 
 367 
Where F is the [6,6-2H2] infusion, V1 is the glucose volume of distribution [4% of 368 
body mass (kg)], E1(t) the [2H2] plasma glucose enrichment (mole percent 369 
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excess) at time t, Ė1 (t) the change in E over time [derivate of E], G(t) the plasma 370 
glucose concentrations at time t, Ġ(t) the change in G over time [derivate of 371 
G],  k12 and k21 are fixed rate constants between the peripheral and the accessible 372 
compartments (0.05 min-1 and 0.07 min-1 respectively) and q2iv and Q2 are the 373 
amounts of the tracer [2H2] and tracee in the peripheral compartment respectively, 374 
evaluated by integrating the two-compartment model.  375 
 376 
The [U-13C] enrichment of the orally ingested glucose and the RaTOTAL (from 377 
Equation 1) were used to calculate the plasma rate of appearance of glucose 378 
from the OGTT (RaOGTT). In these equations, r1 is the ratio of the infusion [2H2] 379 
and oral [U-13C] glucose tracer concentrations in plasma, ṙ (t) is the change in r 380 
over time [derivate of r], g is the [U-13C] glucose tracer in plasma, qoiv is the 381 
amount of the [U-13C] tracer in the peripheral compartment (by integrating the 382 
two-compartment model), and EOGTT is the [U-13C] enrichment of the OGTT. 383 
 384 
Equation 3: 385 
raO(t) =RaTOTAL(t)
F
r1(t)
-
V1∙g(t)
r1(t)
∙ṙ1(t)+k12[
q
2
iv(t)
r1(t)
-q
2
0(t)] 386 
Equation 4: 387 
RaOGTT(t) =ra
O(t)[
1
EOGTT
] 388 
The metabolic clearance rate was calculated as the Rd divided by the plasma 389 
glucose concentrations for a given time point (G1) 390 
 391 
Equation5: 392 
Page 19 
Metabolic Clearance Rate = Rd(t) /G1 393 
Rates of whole-body fat and carbohydrate utilization were calculated using the 394 
expired gas samples and stoichiometric equations (31).  Adjustments were made 395 
to account for the contribution made by the oxidation of protein (estimated via 396 
urinary urea nitrogen). Plasma glucose utilization was assumed to be equivalent 397 
to the plasma glucose rate of disappearance (Rd) as has been confirmed 398 
previously(32). Muscle glycogen utilization during exercise (BE and FE only) was 399 
calculated as total carbohydrate utilization during exercise minus plasma glucose 400 
utilization during exercise. Due to these methods, this estimate of muscle 401 
glycogen utilization will include the utilization of other non-glucose carbohydrates 402 
(e.g. lactate). Both the production and utilization of ketone bodies can influence 403 
the respiratory exchange ratio and therefore theoretically complicate the 404 
estimates of carbohydrate oxidation during exercise. However, during short-405 
duration, moderate intensity exercise this effect is negligible (31). Within-lab, 406 
energy expenditure was determined assuming that lipids, glucose and glycogen 407 
give 40.81, 15.64 and 17.36 kJ·g-1 respectively (31).  408 
 409 
One-way, repeated measures ANOVA were used to assess differences between 410 
trials at baseline and for summary measures (e.g. AUCs). If multiple comparisons 411 
were necessary, two-way repeated measures ANOVAs (time x trial) was used to 412 
identify differences between trials. Degrees of freedom for F values were 413 
Greenhouse-Geisser corrected for epsilon < 0.75, with Huynh-Feldt corrections 414 
used for less severe asphericity. If time x trial interaction effects were identified, 415 
multiple paired t-tests were used to locate variance, with Holm-Bonferroni step-416 
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wise adjustments to control for inflated type I errors. Pearson r and Spearman R 417 
were used to explore correlations between variables display normal and non-418 
normal distribution, respectively. Unless otherwise stated, data in text, figures 419 
and tables are means ± 95% confidence intervals, which were normalized by 420 
removing between-subject variance (presented as 95% nCI)(39). All statistical 421 
analyses were completed using IBM SPSS statistics version 22 for windows 422 
(IBM, New York, USA), with the exception of the Holm-Bonferroni step-wise 423 
adjustments and the calculation of normalized confidence intervals which were 424 
completed using Microsoft Excel [2013]. Graph Pad Prism 7 software (La Jolla, 425 
CA, USA) was used for preparation of the manuscript figures. A complete set of 426 
muscle samples was only obtained from nine participants. Due to cannulation 427 
difficulties, for one participant’s BR trial the last blood sample obtained was at 428 
OGTT 70 min and for a different participant’s BE trial the last sample was at 429 
OGTT 60 min. For these trials (2 of 36) the group average was used for the 430 
missing data. Sensitivity analysis was completed for all measures involving blood 431 
samples and including/excluding these two participants did not influence any of 432 
the primary outcome measures. For clarity, the n is presented in all figure and 433 
table legends. 434 
  435 
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RESULTS 436 
Plasma glucose kinetics 437 
The plasma glucose disappearance rate (Rd) displayed a time x trial interaction 438 
(F = 3.123, p = 0.05), whereby plasma glucose Rd was higher during exercise 439 
versus rest (Figure 2A). Compared to extended overnight fasting, breakfast 440 
ingestion prior to exercise further increased the plasma glucose Rd during and 441 
after exercise (i.e. during the OGTT; Figure 2A). A main effect of trial was 442 
detected for the plasma glucose Rd during the OGTT (F = 7.079, p = 0.01), 443 
whereby the Rd was 45 g·120 min-1 in BR [95% nCI: 36 to 62 g·120 min-1] versus 444 
73 g·120 min-1 in BE ([95% nCI: 55 to 90 g·120 min-1; p = 0.09 versus BR) and 44 445 
g·120 min-1 in FE [95% nCI: 35 to 53 g·120 min-1]; p = 0.01 versus BE). Metabolic 446 
clearance rates showed a main effect of trial, with the highest rates also apparent 447 
in BE (Figure 2B; F = 7.849, p < 0.01 versus BR and FE).  448 
 449 
A main effect of trial was detected for RaTOTAL during the OGTT ([g·120 min-1]; F 450 
= 3.915, p = 0.05) which was highest in BE (Figure 2C). However, after post-hoc 451 
adjustment the difference between trials was less apparent (p = 0.19 for BE 452 
versus BR and p = 0.09 for BE versus FE). A similar pattern was observed for the 453 
rate of appearance of glucose from the OGTT in plasma (RaOGTT) and a trial x 454 
time interaction was detected (Figure 2D; F = 3.134, p = 0.04). A main effect of 455 
trial was detected for the total RaOGTT (F = 5.915, p = 0.02), which was 49 g·120 456 
min-1 in BE [95% nCI: 44 to 53 g·120 min-1] (65% of the OGTT [59 to 71%]) versus 457 
42 g·120 min-1 in BR [95% nCI: 36 to 46 g·120 min-1] (56% of the OGTT [50 to 458 
62%]; p = 0.11 versus BE) and 41 g·120 min-1 in FE [95% nCI: 35 to 47 g] (55% 459 
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of the OGTT [49 to 61%] p = 0.06 versus BE). The plasma enrichment of [2H2] - 460 
and [13C]- glucose are shown in Figures 2E and 2F, respectively.  461 
 462 
Plasma glucose concentrations 463 
No difference between trials was detected for plasma glucose concentrations at 464 
baseline (Figure 3A; p > 0.05). Thereafter, a trial x time interaction was apparent 465 
(F = 2.957, p = 0.01). During the exercise period (rest in BR), plasma glucose 466 
concentrations were higher in BR versus BE at 40 min, and in BR versus FE at 467 
50 min (both p < 0.05). At OGTT 0 min, glucose concentrations were higher in 468 
BR versus BE, and during the OGTT they were initially higher in BR versus BE 469 
and in BR versus FE (all p < 0.05), but no further differences were then detected 470 
(Figure 3A). Peak plasma glucose concentrations were higher in BR versus BE 471 
(p = 0.03), but not different in BE versus FE (Table 2; p > 0.05). A main effect of 472 
trial was detected for the within-lab (300-min) glucose AUC which was higher in 473 
BR versus BE (Table 2; p = 0.05). However, no main effect of trial was detected 474 
for the OGTT (120-min) iAUC (Figure 4A; F = 2.524, p = 0.11). 475 
  476 
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Figure 2. The plasma glucose disposal rate (Rd) (A), metabolic clearance rate  (B), the 
total rate of plasma glucose appearance (RaTOTAL) (C), the rate of appearance of glucose 
in plasma from the oral glucose tolerance test (RaOGTT) (D), and the plasma enrichments of 
[2H2]-glucose (E) and [13C]-glucose (F) before and during an oral glucose tolerance test that 
was conducted after breakfast followed by rest (BREAKFAST-REST), breakfast followed 
by exercise (BREAKFAST-EX), or extended overnight fasting followed by exercise 
(FASTED-EX). Data are means ± normalized 95% confidence intervals. n = 12 healthy men. 
a = difference between breakfast rest versus breakfast exercise; b = breakfast rest versus 
fasted exercise and c = breakfast exercise versus fasted exercise with p < 0.05. 
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 478 
479 
Figure 3. Plasma glucose (A), plasma insulin (B), plasma non-esterified fatty acids 
(NEFA; C), plasma β-hydroxybuturate (D) plasma triglyceride (E), and plasma 
intestinal fatty acid binding protein (IFAB-P; F) concentrations before and during an 
oral glucose tolerance test that was conducted after breakfast followed by rest 
(BREAKFAST-REST), breakfast followed by exercise (BREAKFAST-EX), or extended 
overnight fasting followed by exercise (FASTED-EX). Data are means ± normalized 
95% confidence intervals. n = 12 healthy men. a = difference between breakfast rest 
versus breakfast exercise; b = breakfast rest versus fasted exercise and c = breakfast 
exercise versus fasted exercise with p < 0.05. 
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  480 
Figure 4. The time-averaged (120-min) plasma glucose (A) and plasma 
insulin (B) incremental area under the curves (iAUC) and the Matsuda insulin 
sensitivity index (C; ISIMATSUDA) for an oral glucose tolerance test conducted 
after breakfast followed by rest (BREAKFAST-REST), breakfast followed by 
exercise (BREAKFAST-EX), or extended overnight fasting followed by 
exercise (FASTED-EX). Data are means ± normalized 95% confidence 
intervals, with individual data shown as grey lines. n = 12 healthy men. 
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Plasma insulin concentrations 481 
At baseline, there was no difference between trials for plasma insulin 482 
concentrations (Figure 3B; p > 0.05). Main effects of time (F = 4.351, p < 0.01) 483 
and trial (F = 7.986, p < 0.01) were detected, but there was no trial x time 484 
interaction effect (F = 2.395, p = 0.07). Peak (and time to peak) plasma insulin 485 
concentrations are shown in Table 2. A main effect of trial was detected for the 486 
within-lab (300-min) insulin AUC which was higher in BR versus BE (p < 0.01), 487 
but not different in BE versus FE (Table 2; p = 0.10). A main effect of trial was 488 
apparent for the insulin OGTT iAUC [Figure 4B; (120-min) F = 5.132, p = 0.02] 489 
which was lower in BE versus BR [by 27.34 pmol·L-1 (95% nCI: 12.10 to 45.80 490 
pmol·L-1); p = 0.02] and lower in BE versus FE [by 28.67 pmol·L-1 (95% nCI: 10.21 491 
to 47.12 pmol·L-1); p = 0.04]. There was a main effect of trial for the ISIMATSUDA 492 
insulin sensitivity index (Figure 4C; F = 22.790, p < 0.01), which was higher in 493 
BE versus BR [by 8.45 au, (95% nCI: 6.42 to 10.47 au); p < 0.01] and in BE 494 
versus FE [by 6.49 au (95% nCI: 2.93 to 8.51 au); p < 0.01]. 495 
 496 
Plasma non-esterified fatty acid (NEFA) concentrations 497 
A main effect of trial (F = 4.314, p = 0.04) was detected for plasma NEFA at 498 
baseline, with concentrations of 0.30 mmol·L-1 in BR (95% nCI: 0.25 to 0.35 499 
mmol·L-1), 0.45 mmol·L-1 in BE (95% nCI: 0.36 to 0.53 mmol·L-1; p = 0.03 BE 500 
versus BR) and 0.36 mmol·L-1 in FE (95% nCI: 0.31 to 0.44 mmol·L-1; p = 0.12 501 
FE versus BR and BE). Thereafter, a time x trial interaction effect was apparent 502 
(Figure 3C; F = 11.438, p < 0.01), where plasma NEFA concentrations were 503 
lowered by breakfast consumption in BR and BE, and remained lower during the 504 
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exercise in BE versus FE, before increasing during the initial OGTT period in BE 505 
and FE versus BR. A main effect of trial was detected for the total within-lab  506 
plasma NEFA (300-min) AUC and the NEFA OGTT (120-min) AUC which in both 507 
instances was lower in BR versus BE and FE (Table 2; all p < 0.01).   508 
 509 
Other plasma metabolites  510 
No differences were detected between trials at baseline for plasma β-511 
hydroxybuturate concentrations (Figure 3D; p > 0.05). Thereafter, a time x trial 512 
interaction effect was apparent (F = 6.310, p < 0.01) where concentrations were 513 
lowered by breakfast in BR and BE. Plasma β-hydroxybuturate concentrations 514 
remained lower during exercise in BE versus FE, but increased during the OGTT 515 
with BE and FE versus BR. However, with post-hoc adjustment, the differences 516 
between trials for plasma β-hydroxybuturate concentrations became less clear 517 
(all p > 0.05). The within-lab (300-min) β-hydroxybuturate AUC was lower with 518 
BR versus BE (p = 0.03), but did not differ in BE and FE (Table 2; p = 0.35).  No 519 
baseline differences were detected for triglyceride concentrations (Figure 3E, p 520 
> 0.05) but a time x trial interaction effect was apparent (F = 3.994, p < 0.01). 521 
There was an effect of trial for the within-lab (300-min) and OGTT (120-min) 522 
triglyceride AUC, which tended to be lower in FE versus BE, but with post-hoc 523 
adjustment this difference between trials was less clear (Table 2; p > 0.05). 524 
Plasma lactate concentrations at baseline were not different across trials (p > 525 
0.05) but were lower in BR versus BE and FE in the exercise period (rest in BR) 526 
and at OGTT 0 min, but were then higher in BR versus BE during the OGTT (time 527 
x trial; F = 20.305, p < 0.01). No effect of trial was detected for the total within-lab 528 
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(300-min) lactate AUC, but a main effect of trial was detected for the lactate 529 
OGTT (120-min) AUC, which higher in BR versus BE (Table 2; p < 0.01).  530 
 531 
Plasma intestinal fatty acid binding protein (I-FABP) concentrations 532 
There was no difference between trials at baseline for plasma I-FABP 533 
concentrations (Figure 3F; p > 0.05), but these were lower after breakfast (time 534 
x trial interaction effect; F = 6.844, p < 0.01) in BR and BE versus FE (both p < 535 
0.05). During and post-exercise (or rest in BR), I-FABP concentrations were lower 536 
in BR and BE versus FE and remained lower in BR versus FE until OGTT 20 min 537 
(all p < 0.05). The within-lab (300-min) I-FABP AUC was lower in BR and BE 538 
versus FE (Table 2; p = 0.01 and p = 0.05 respectively).  539 
 540 
Activation of exercise and insulin signaling pathways in skeletal muscle 541 
Time x trial interaction effects were apparent for AMPKThr172 (ratio p-AMPK to 542 
total-AMPK) and ACCSer79 (ratio pACC to total ACC) phosphorylation, if 543 
normalized to the baseline muscle sample (Figure 5A; F = 5.154, p = 0.04 and 544 
Figure 5B, F = 5.881, p = 0.02, respectively). Compared to the breakfast-rest trial 545 
(BR), skeletal muscle AMPKThr172 phosphorylation was higher post-exercise (or 546 
post-rest in BR) in the breakfast and exercise (BE) trial [by 1.9 fold (95% nCI: 0.9 547 
to 2.8 fold); p = 0.04] and was also higher in BE versus the fasted-exercise (FE) 548 
trial [by 1.0 fold (95% nCI: 0.2 to 2.0 fold); p = 0.01]. A similar pattern was 549 
apparent for ACC phosphorylation, which was higher post-exercise (or post-rest 550 
in BR) in BE versus BR [by 6.7 fold (95% nCI: 5.4 to 8.0 fold); p = 0.03] but did 551 
not differ between BE and FE (p = 0.09). By OGTT 120 min, ACCSer79 and 552 
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AMPKThr172 phosphorylation had returned to baseline levels in all three trials (all 553 
p > 0.05). No time x trial interaction (F = 2.110, p = 0.16) nor a main effect of trial 554 
(F = 0.098, p = 0.83) was detected for AktSer473 (ratio p-AktSer473 to total-Akt2) 555 
phosphorylation (Figure 6A). A main effect of time (F = 9.907, p = 0.01) was 556 
observed, where AktSer473 phosphorylation was elevated at OGTT 120 min in all 557 
trials. Similarly no time x trial interaction (F = 1.533, p = 0.25) nor a main effect of 558 
trial (F = 0.484, p = 0.56) was detected for AktThr308 (ratio p-AktThr308 to total-Akt2) 559 
phosphorylation (Figure 6B). A main effect of time (F = 10.598, p = 0.01) was 560 
also detected for this phosphorylation site, whereby AktThr308 phosphorylation was 561 
elevated at OGTT 120 min in all trials. For AS160Thr642 phosphorylation (ratio p-562 
AS160Thr642 to total-AS160), a time x trial interaction was detected (Figure 6C; F 563 
= 4.430, p = 0.03), whereby the AS160Thr642 phosphorylation was not different 564 
between BR and BE at any time, was higher pre-OGTT in BE compared to FE (p 565 
= 0.04), but was not different between BE and FE at 120-min post-OGTT (p = 566 
0.69).  567 
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  568 
Figure 5. The phosphorylation of 5' AMP-activated protein kinase (A; phospho AMPKThr172, 
ratio p-AMPK to total-AMPK) and the phosphorylation of acetyl-CoA carboxylase (B; 
phospho ACCSer79, ratio p-ACC to total-ACC) before (PRE-OGTT) and after (POST-OGTT) 
an oral glucose tolerance test that was conducted after breakfast followed by rest 
(BREAKFAST-REST [BR]), breakfast followed by exercise (BREAKFAST-EX [BE]), or 
extended overnight fasting followed by exercise (FASTED-EX [FE]). All samples were taken 
from the vastus lateralis. Samples were normalized to the baseline muscle sample for each 
participant (collected in the resting fasted state on the first main trial for each participant). 
Data are means ± normalized 95% confidence intervals. n = 9 healthy men. 
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 573 
 574 
 575 
 576 
 577 
 578 
Figure 6. The phosphorylation of Akt2 (A; phospho AktSer473, ratio p-Akt Ser473 to total-Akt2 
and B; phosphor AktThr308, ratio p-AktThr308 to total-Akt2) and the phosphorylation of AS160 
(C; AS160Thr642, ratio p-AS160Thr642 to total-AS160) before (PRE-OGTT) and after (POST-
OGTT) an oral glucose tolerance test that was conducted after breakfast followed by rest 
(BREAKFAST-REST [BR]), breakfast followed by exercise (BREAKFAST-EX [BE]), or 
extended overnight fasting followed by exercise (FASTED-EX [FE]). All samples were taken 
from the vastus lateralis. Samples were normalized to the baseline muscle sample for each 
participant (collected in the resting fasted state on the first main trial for each participant). 
Data are means ± normalized 95% confidence intervals. n = 9 healthy men. 
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Substrate utilization 579 
Across the duration of the trial carbohydrate utilization was higher in BE versus 580 
BR (Figure 7; by 514 kcal, [95% nCI: 452 to 576 kcal] and higher in BE versus 581 
FE (by 124 kcal, [95% nCI: 18 to 230 kcal], both p < 0.01). This difference in 582 
carbohydrate utilization between BE and FE was derived from a higher utilization 583 
of plasma glucose and other carbohydrate sources (i.e. primarily muscle 584 
glycogen, but also plasma lactate) in BE (p = 0.02 and p = 0.04 respectively). 585 
Within-lab fat utilization did not differ between BR and BE (p = 0.25), but was 586 
higher in FE versus BE (by 138 kcal, [95% nCI: -6 to 224 kcal], p = 0.03). Muscle 587 
glycogen utilization during exercise (g·kg body mass-1) was positively correlated 588 
(R = 0.64, p < 0.01) with skeletal muscle ACCSer79 phosphorylation (ratio p-ACC 589 
to total-ACC) after exercise conducted following breakfast consumption (BE) or 590 
extended overnight fasting (FE).  591 
  592 
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 593 
  594 
Figure 7. Substrate utilization after breakfast followed by rest (BREAKFAST-
REST), breakfast followed by exercise (BREAKFAST-EX), or extended 
overnight fasting followed by exercise (FASTED-EX). Within-lab substrate 
utilization was calculated assuming that the plasma glucose disappearance 
rate was equivalent to plasma glucose utilization. Glycogen utilization during 
exercise (on breakfast exercise and fasted exercise only) was calculated as 
total carbohydrate utilization (from indirect calorimetry) minus plasma glucose 
utilization during exercise. This estimate of muscle glycogen utilization will 
therefore include the utilization of other non-glucose (e.g. lactate) 
carbohydrates. GLU = glucose; M-GLY = muscle glycogen; PRO = protein. 
Data are presented as means ± normalized 95% confidence intervals. n = 12 
healthy men.  
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DISCUSSION  595 
This is the first study to assess the effect of pre-exercise feeding on postprandial 596 
plasma glucose kinetics after exercise. Our data demonstrate that pre-exercise 597 
feeding increases plasma glucose disposal during meals consumed after 598 
exercise, despite lower insulinemia in this condition. Characterizing glucose flux 599 
at meals is important because this determines postprandial glycemia; a predictor 600 
of cardiovascular disease risk (47, 48). Previous work has only studied 601 
postprandial glucose flux after fasted-state exercise. As most people consume 602 
food and perform exercise while still in a postprandial period from a prior meal 603 
(13, 23, 55) our results describe the physiological responses to feeding that are 604 
more readily applicable to scenarios that are representative of normal daily living. 605 
Moreover, our novel data demonstrate that metabolic responses to exercise 606 
conducted in an overnight fasted state and to meals that are consumed post-607 
exercise cannot be easily extrapolated to conditions where breakfast has been 608 
consumed. 609 
 610 
The disposal of plasma glucose (the disappearance rate) into skeletal muscle is 611 
elevated after exercise, via insulin-dependent and -independent pathways (25). 612 
We observed a higher postprandial plasma glucose disposal rate with breakfast 613 
versus fasting before exercise. The higher postprandial plasma glucose rate of 614 
disposal with pre-exercise breakfast ingestion was apparent despite lower 615 
insulinemia in the breakfast-exercise trial. At rest, breakfast consumption 616 
improves glucose tolerance and insulin sensitivity at subsequent meals [known 617 
as the “second-meal effect” (5, 20, 26)]. Mechanisms likely relate to delayed 618 
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gastric emptying (19), a potentiation of early phase insulinemia at the second 619 
meal (37) and enhanced glucose uptake into muscle due to increased GLUT4 620 
trafficking (18). Our findings show that breakfast ingestion (versus fasting) prior 621 
to exercise enhances subsequent glucose disposal at post-exercise meals in the 622 
presence of lower insulinemia, suggesting that the second-meal effect is 623 
maintained even if exercise is performed between meals. Whilst the effects of 624 
pre-exercise feeding on the metabolic responses during subsequent exercise is 625 
well characterised (15, 43), our data therefore provide new insights regarding 626 
postprandial glucose metabolism after exercise in the fed versus fasted state. 627 
 628 
Molecular insulin-signaling pathways are instrumental mediators of glucose 629 
disposal in response to exercise and/or nutrition (11). We therefore determined 630 
the activation status of key proteins involved in glucose uptake in skeletal muscle 631 
[the primary site of postprandial glucose disposal (14)]. Akt activation (Thr308 and 632 
Ser473 phosphorylation) two hours after OGTT began, was unaffected by prior 633 
exercise or prior breakfast ingestion. However, the timing of muscle sampling 634 
could be responsible for this result. It is possible that differences in Akt activation 635 
between trials may have been apparent earlier in the postprandial period, as peak 636 
Akt phosphorylation can be variable, occurring as early as 30 min after an OGTT 637 
(35). Thus, despite the lack of a measurable difference, we cannot rule out a role 638 
for insulin signaling in the glucose disposal responses we observed. Distal 639 
proteins within the insulin signalling pathway can be activated after exercise, 640 
without detectable differences in Akt phosphorylation (61). We therefore 641 
measured AS160Thr642 activation as this phosphorylation site has been previously 642 
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shown to be activated by both insulin and exercise stimulation (58). However, our 643 
data show that AS160Thr642 phosphorylation was not different two hours post-644 
OGTT with breakfast versus fasting before exercise, providing further evidence 645 
that differences in early stages of the activation of the insulin signalling pathway 646 
were not responsible for the higher plasma glucose disposal rate we observed 647 
when breakfast was ingested before exercise. 648 
 649 
AMPK activity also plays a key role in muscle glucose uptake and stimulate 650 
GLUT4 translocation (27). The greater post-exercise skeletal muscle AMPK 651 
activation with breakfast prior to exercise may have contributed to the higher 652 
glucose disposal rate in that trial. This AMPK response seems to be specific to 653 
skeletal muscle, as we have previously shown that post-exercise adipose tissue 654 
AMPK content is unaffected by pre-exercise feeding (12). The increase in skeletal 655 
muscle AMPK activity with pre-exercise feeding that we report in the present 656 
study may seem surprising given that the ingestion of large amounts (> 200 g) of 657 
carbohydrate before and during exercise can blunt AMPK signaling in muscle (3, 658 
29). This blunting is partly because low muscle glycogen concentrations stimulate 659 
AMPK activity (42). The modest amount (65 g) of carbohydrate ingested by 660 
participants in our study may explain why we did not observe an elevated AMPK 661 
response in our fasted-exercise trial. For example, when smaller carbohydrate 662 
doses are ingested before and/or during exercise (~ 120 g or less) the exercise 663 
induced increase in the phosphorylation of AMPK and ACC is not always 664 
suppressed compared to when a placebo is ingested (2, 36, 58), although in one 665 
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study this result was apparent despite a suppression of α2-AMPK activity when 666 
carbohydrate was ingested (2). 667 
 668 
The heightened AMPK response observed in the current study with breakfast 669 
before exercise may be explained by the type of carbohydrate ingested before 670 
exercise (high-glycemic index) in the breakfast-exercise trial, as this can 671 
stimulate muscle glycogen use during exercise, especially when no carbohydrate 672 
is ingested during the activity (62). Thus, the high-glycemic index breakfast with 673 
a modest carbohydrate content in the present study, may have stimulated muscle 674 
glycogen utilization during exercise without supplying sufficient carbohydrate to 675 
replace additional glycogen utilization, resulting in lower post-exercise muscle 676 
glycogen concentrations with breakfast versus fasting before exercise. This could 677 
explain the enhanced exercise-induced AMPK response if breakfast was 678 
consumed prior to exercise. However, we had insufficient tissue to measure 679 
muscle glycogen concentrations in all participants, and our data only provide 680 
rates of muscle glycogen utilization (which was higher with feeding versus fasting 681 
before exercise). Nevertheless, in the two participants for whom we had sufficient 682 
tissue to perform glycogen analyses, these data were in agreement with the 683 
tracer-derived calculations of muscle glycogen utilization (data not shown) and 684 
AMPK signaling assessed by western blotting. Consistent with this, the present 685 
data demonstrated that post-exercise ACCSer79 phosphorylation – as a marker of 686 
activation of the AMPK pathway - positively correlated with muscle glycogen 687 
utilization during exercise. Thus, taken together our results suggest that the 688 
increased post-exercise plasma glucose disposal rates with pre-exercise feeding 689 
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versus fasting may have been mediated through enhanced AMPK signaling, 690 
which is itself a consequence of altered fuel use during exercise. AMPK signaling 691 
and resulting muscle glycogen concentrations following exercise after breakfast 692 
should now be explored.  693 
 694 
The higher plasma glucose disposal rate (despite lower plasma insulin 695 
concentrations), that we observed in the breakfast-exercise trial, may be due to 696 
differences in GLUT4 trafficking downstream of the signalling proteins we 697 
measured. Insulin-stimulated GLUT4 translocation and insulin sensitivity of 698 
skeletal muscle are increased in vitro, if muscle is pre-treated with insulin, without 699 
differences in AktSer473 or AktThr308 activation, or the transport activity of GLUT4 700 
(18). This suggests priming of skeletal muscle by prior insulin exposure enhances 701 
subsequent insulin action. Pre-treatment with insulin and exercise augments this 702 
response, possibly because insulin (33) and exercise (28) stimulate GLUT4 703 
translocation from different intracellular stores (8, 49). As such, in the current 704 
work, prior breakfast and exercise (the multiple stimuli in BE), may have 705 
enhanced skeletal muscle GLUT4 translocation during the OGTT. Although 706 
technically challenging future work should now quantify GLUT4 trafficking with 707 
fed versus fasted state exercise to confirm this. It is also possible that hepatic 708 
glucose disposal accounts for some of the increase in glucose disposal following 709 
BE versus FE. Similarly to skeletal muscle, insulin-stimulated hepatic glucose 710 
uptake is enhanced by prior exposure to insulin in dogs (44, 45). Thus, assuming 711 
that this response persists in humans and after exercise, priming of the liver by 712 
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prior breakfast could also contribute to greater glucose disposal during meals 713 
consumed post-exercise. 714 
 715 
The increases in post-exercise glucose disposal with prior breakfast consumption 716 
were, however, offset by alterations in plasma glucose appearance. As such, 717 
postprandial glucose concentrations did not differ between the two exercise trials. 718 
Postprandial plasma glucose appearance rates are determined by three main 719 
factors: 1) the appearance of glucose from the meal; 2) residual appearance of 720 
glucose from previous meals; and/or 3) liver glucose output (glycogenolysis or 721 
gluconeogenesis). We showed that alterations in the postprandial plasma 722 
glucose appearance rate (RaTOTAL) after exercise with prior breakfast was mostly 723 
driven by increased appearance of glucose from the post-exercise OGTT. These 724 
alterations in the RaTOTAL suggest that differences in gut function (i.e. increased 725 
intestinal damage or absorptive capacity) and/or splanchnic blood flow altered 726 
the RaTOTAL. Thus, breakfast prior to exercise may alter postprandial glycemia via 727 
factors related to intestinal absorption and splanchnic handling of glucose, rather 728 
than just glucose metabolism by skeletal muscle.  729 
 730 
There are several potential mechanisms which may explain the differences in 731 
glucose appearance rates due to intestinal absorption and/or splanchnic handling 732 
of glucose. Plasma I-FABP concentrations are used as a marker of damage to 733 
intestinal epithelial cells (60). We noted lower plasma I-FABP concentrations in 734 
the breakfast-exercise versus fasted-exercise trial, despite increased plasma 735 
glucose appearance rates of the orally-ingested glucose post-exercise. It is 736 
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therefore unlikely that increased intestinal damage was responsible for the higher 737 
plasma glucose appearance rates we observed with feeding versus fasting 738 
before exercise. The better maintenance of splanchnic perfusion during exercise 739 
with prior feeding is a likely explanation for this response (15). If splanchnic 740 
perfusion was better maintained during exercise with prior feeding, this may have 741 
also directly facilitated higher OGTT-derived glucose appearance rates in that 742 
trial versus the fasted-exercise trial. It should be acknowledged however, that this 743 
intestinal damage response may be specific to cycling, and could differ with other 744 
exercise modalities (e.g. running), within the context of pre-exercise feeding. An 745 
alternative mechanism for higher appearance rate of orally-ingested glucose with 746 
feeding before exercise could also be that apical glucose transporters were 747 
primed by the prior breakfast ingestion (40). Although further underlying 748 
mechanism(s) remain unclear, and should therefore be investigated with future 749 
work, we showed that a major determinant of post-exercise glycemia (plasma 750 
glucose appearance rates) are altered by pre-exercise feeding and that this is 751 
unlikely to be explained by increases in intestinal damage.  752 
 753 
Our results show that the metabolic and intramuscular signaling responses to 754 
exercise conducted in a fed state cannot be readily inferred from responses 755 
observed with exercise in a fasted state. As well as a continual investigation of 756 
the mechanisms responsible for differences in postprandial glucose metabolism 757 
with altered pre-exercise feeding, future work should study whether the results 758 
we observed are apparent with different post-exercise meals (including the co-759 
ingestion of fat and protein). Moreover, if the acute alterations in postprandial 760 
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metabolism translate into longer-term differences in insulin sensitivity with 761 
repeated bouts of exercise in the fed versus fasted state, and in overweight and 762 
obese populations, should now be a focus for future work.  763 
 764 
To conclude, eating breakfast (versus fasting) before exercise increases post-765 
exercise plasma glucose disposal rates but this is offset by increases in 766 
appearance rates of (mainly) orally-ingested glucose, a result that does not 767 
appear to be explained by a greater intestinal damage response to the exercise. 768 
We showed that pre-exercise breakfast consumption lowers insulinema at meals 769 
that are consumed post-exercise, providing new evidence that the second meal 770 
effect is maintained even when exercise is performed between eating occasions.  771 
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TABLES  984 
 985 
 986 
Table 1. Participant Characteristics 
Age (y) 23 (3) 
Stature (cm) 179.8 (4.4) 
Body mass (kg) 76.3 (7.9) 
Body Mass Index (kg·m-2) 23.6 (2.90) 
Fat mass (kg)1 10.6 (3.7) 
Fat Mass Index (kg·m-2)1 3.26 (1.12) 
Body fat (%)1 14 (4) 
Fat free mass (kg)1 65.5 (6.4) 
V̇O2peak (L·min-1) * 4.00 (0.72) 
V̇O2peak (mL·kg·min-1) * 53 (10) 
Peak Power Output (W) 317 (67) 
HRMAX, (beats·min-1) 189 (10) 
Data are presented as means and (standard deviation). V̇O2peak = peak 
oxygen uptake. n = 12. *n = 11, due to technical difficulties with the breath-
by-breath analysis during one participant’s preliminary testing. 1 = derived by 
dual-energy x-ray absorptiometry (DEXA). 
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 988 
Table 2. Peak plasma concentrations, time to peak concentrations, and the time-averaged area under 
the curve (AUC) for various metabolites and hormones measured during the total within-lab period 
(300-min) and/or during an oral glucose tolerance test observation (120-min) that was conducted after 
breakfast followed by rest (Breakfast-Rest), breakfast followed by exercise (Breakfast-Exercise), or 
extended overnight fasting followed by exercise (Fasted-Exercise). 
 Breakfast-
Rest 
Breakfast-
Exercise 
Fasted-
Exercise 
 
Peak glucose conc. (mmol·L 1) 10.62 (9.98, 11.25) 9.65 (9.27, 10.03) a 9.82 (9.44, 10.45) F = 4.895, p = 0.03 
Time to peak glucose (min) 36 (24, 47) 49 (36, 62) 49 (36, 61) F = 2.588, p = 0.12 
Glucose AUCTOTAL (mmol·L-1) 6.41 (6.21, 6.60) 6.05 (5.90, 6.15) a 6.07 (5.93, 6.27) F = 6.126, p = 0.01 
Peak insulin conc. (pmol·L-1) 286 (231, 341) 209 (148, 269) 282 (222, 337) F = 3.900, p = 0.07 
Time to peak insulin (min) 38 (26, 49) 56 (47, 65) a 43 (33, 54) F = 4.579, p = 0.03 
Insulin AUCTOTAL (pmol·L-1) 88 (79, 97) 62 (54, 71) aa 76 (67, 85) F = 9.28, p < 0.01 
NEFA AUCTOTAL(mmol·L-1) 0.16 (0.12, 0.19) 0.28 (0.24, 0.33)aa 0.37 (0.31,0.42)bb F = 24.98, p < 0.01 
NEFA AUCOGTT (mmol·L-1) 0.10 (0.06, 0.14) 0.24 (0.20, 20.29) aa 0.26 (0.22, 0.31) bb F = 15.51, p < 0.01 
Triglyceride AUCTOTAL (mmol·L-1) 0.85 (0.79, 0.91) 0.81 (0.75, 0.86) 0.75 (0.70, 0.79) F = 4.319, p = 0.03 
Triglyceride AUCOGTT (mmol·L-1) 0.84 (0.77, 0.92) 0.79 (0.72, 0.86) 0.70 (0.64, 0.77) F = 4.677, p = 0.02 
Lactate AUCTOTAL (mmol·L-1) 1.05 (0.96, 1.13) 1.19 (1.08, 1.30) 1.16 (1.07, 1.27) F = 3.645, p = 0.06 
Lactate AUCOGTT (mmol·L-1) 1.12 (1.04, 1.20) 0.97 (0.89, 1.04) aa 1.03 (0.96, 1.11) F = 6.479, p = 0.02 
β-hydroxybuturate AUCTOTAL 
(mmol·L-1) 
0.03 (0.00, 0.06) 0.08 (0.06, 0.13) a 0.14 (0.09, 0.19) b F = 5.936, p = 0.03 
I-FABP AUCTOTAL (pg·mL-1) 279 (242, 317) 304 (267, 366) 415 (353, 476) b cc F = 10.87, p < 0.01 
Data are means and (normalized 95% confidence intervals). conc. = concentration; AUCTOTAL = the time-
averaged area underneath the concentration-time curve for the total within-lab period (300-min); AUCOGTT = the 
time-averaged area underneath the concentration-time curve for the oral glucose tolerance test (120-min); I-
FABP = intestinal fatty acid binding protein. n = 12 healthy men a represents a difference between breakfast 
rest and breakfast exercise, b a difference between breakfast rest and fasted exercise and c a difference 
between  breakfast exercise  and  fasted exercise with p < 0.05. aa, bb or cc is the same difference between 
trials but with p < 0.01. 
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LEGENDS TO FIGURES 989 
Figure 1. Protocol schematic. An oral glucose tolerance test was conducted after 990 
breakfast followed by rest (BR), breakfast followed by exercise (BE), or extended 991 
overnight fasting followed by exercise (FE). Dual stable isotope tracers ([U-13C] 992 
glucose ingestion and [6,6-2H2] glucose infusion) and muscle biopsies were 993 
combined to assess postprandial plasma glucose kinetics and intramuscular 994 
signaling, respectively. 995 
 996 
 997 
Figure 2. The plasma glucose disposal rate (Rd) (A), metabolic clearance rate  998 
(B), the total rate of plasma glucose appearance (RaTOTAL) (C), the rate of 999 
appearance of glucose in plasma from the oral glucose tolerance test (RaOGTT) 1000 
(D), and the plasma enrichments of [2H2]-glucose (E) and [13C]-glucose (F) before 1001 
and during an oral glucose tolerance test that was conducted after breakfast 1002 
followed by rest (BREAKFAST-REST), breakfast followed by exercise 1003 
(BREAKFAST-EX), or extended overnight fasting followed by exercise (FASTED-1004 
EX). Data are means ± normalized 95% confidence intervals. n = 12 healthy men. 1005 
a = difference between breakfast rest versus breakfast exercise; b = breakfast 1006 
rest versus fasted exercise and c = breakfast exercise versus fasted exercise 1007 
with p < 0.05. 1008 
 1009 
Figure 3. Plasma glucose (A), plasma insulin (B), plasma non-esterified fatty 1010 
acids (NEFA; C), plasma β-hydroxybuturate (D) plasma triglyceride (E), and 1011 
plasma intestinal fatty acid binding protein (IFAB-P; F) concentrations before and 1012 
during an oral glucose tolerance test that was conducted after breakfast followed 1013 
by rest (BREAKFAST-REST), breakfast followed by exercise (BREAKFAST-EX), 1014 
or extended overnight fasting followed by exercise (FASTED-EX). Data are 1015 
means ± normalized 95% confidence intervals. n = 12 healthy men. a = difference 1016 
between breakfast rest versus breakfast exercise; b = breakfast rest versus 1017 
fasted exercise and c = breakfast exercise versus fasted exercise with p < 0.05. 1018 
 1019 
Figure 4. The time-averaged (120-min) plasma glucose (A) and plasma insulin 1020 
(B) incremental area under the curves (iAUC) and the Matsuda insulin sensitivity 1021 
index (C; ISIMATSUDA) for an oral glucose tolerance test conducted after breakfast 1022 
followed by rest (BREAKFAST-REST), breakfast followed by exercise 1023 
(BREAKFAST-EX), or extended overnight fasting followed by exercise (FASTED-1024 
EX). Data are means ± normalized 95% confidence intervals, with individual data 1025 
shown as grey lines. n = 12 healthy men. 1026 
 1027 
Figure 5. The phosphorylation of 5' AMP-activated protein kinase (A; phospho 1028 
AMPKThr172, ratio p-AMPK to total-AMPK) and the phosphorylation of acetyl-CoA 1029 
carboxylase (B; phospho ACCSer79, ratio p-ACC to total-ACC) before (PRE-1030 
OGTT) and after (POST-OGTT) an oral glucose tolerance test that was 1031 
conducted after breakfast followed by rest (BREAKFAST-REST [BR]), breakfast 1032 
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followed by exercise (BREAKFAST-EX [BE]), or extended overnight fasting 1033 
followed by exercise (FASTED-EX [FE]). All samples were taken from the vastus 1034 
lateralis. Samples were normalized to the baseline muscle sample for each 1035 
participant (collected in the resting fasted state on the first main trial for each 1036 
participant). Data are means ± normalized 95% confidence intervals. n = 9 1037 
healthy men. 1038 
 1039 
Figure 6. The phosphorylation of Akt2 (A; phospho AktSer473, ratio p-Akt Ser473 to 1040 
total-Akt2 and B; phosphor AktThr308, ratio p-AktThr308 to total-Akt2) and the 1041 
phosphorylation of AS160 (C; AS160Thr642, ratio p-AS160Thr642 to total-AS160) 1042 
before (PRE-OGTT) and after (POST-OGTT) an oral glucose tolerance test that 1043 
was conducted after breakfast followed by rest (BREAKFAST-REST [BR]), 1044 
breakfast followed by exercise (BREAKFAST-EX [BE]), or extended overnight 1045 
fasting followed by exercise (FASTED-EX [FE]). All samples were taken from the 1046 
vastus lateralis. Samples were normalized to the baseline muscle sample for 1047 
each participant (collected in the resting fasted state on the first main trial for each 1048 
participant). Data are means ± normalized 95% confidence intervals. n = 9 1049 
healthy men. 1050 
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Figure 7. Within-lab (300-min) substrate utilization after breakfast followed by 1052 
rest (BREAKFAST-REST), breakfast followed by exercise (BREAKFAST-EX), or 1053 
extended overnight fasting followed by exercise (FASTED-EX). Within-lab 1054 
substrate utilization was calculated assuming that the plasma glucose 1055 
disappearance rate was equivalent to plasma glucose utilization. Glycogen 1056 
utilization during exercise (on breakfast exercise and fasted exercise only) was 1057 
calculated as total carbohydrate utilization (from indirect calorimetry) minus 1058 
plasma glucose utilization during exercise. This estimate of muscle glycogen 1059 
utilization will therefore include the utilization of other non-glucose (e.g. lactate) 1060 
carbohydrates. GLU = glucose; M-GLY = muscle glycogen; PRO = protein; CHO 1061 
= carbohydrate. Data are presented as means ± 95% confidence intervals. n = 1062 
12 healthy men.  1063 
